Population-based analysis of CNS tumor diagnoses, treatment, and survival in congenital and infant age groups.

Subtype distribution, treatment patterns, and prognosis of congenital/infant CNS tumors differ from those in older children. Better, more standardized treatment guidelines may improve poorer outcomes seen in these youngest patients.